- Home
- CRNX vs MFC Comparison
CRNX vs MFC Comparison
Compare CRNX & MFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRNX
- MFC
- Stock Information
- Founded
- CRNX 2008
- MFC 1887
- Country
- CRNX United States
- MFC Canada
- Employees
- CRNX N/A
- MFC N/A
- Industry
- CRNX Biotechnology: Pharmaceutical Preparations
- MFC Life Insurance
- Sector
- CRNX Health Care
- MFC Finance
- Exchange
- CRNX Nasdaq
- MFC Nasdaq
- Market Cap
- CRNX 2.8B
- MFC 51.7B
- IPO Year
- CRNX 2018
- MFC 1999
- Fundamental
- Price
- CRNX $34.20
- MFC $31.03
- Analyst Decision
- CRNX Strong Buy
- MFC Buy
- Analyst Count
- CRNX 7
- MFC 1
- Target Price
- CRNX $74.33
- MFC $49.00
- AVG Volume (30 Days)
- CRNX 1.1M
- MFC 1.8M
- Earning Date
- CRNX 11-11-2025
- MFC 11-05-2025
- Dividend Yield
- CRNX N/A
- MFC 3.93%
- EPS Growth
- CRNX N/A
- MFC 33.03
- EPS
- CRNX N/A
- MFC 2.29
- Revenue
- CRNX $1,392,000.00
- MFC $22,915,108,577.00
- Revenue This Year
- CRNX $489.51
- MFC $34.27
- Revenue Next Year
- CRNX $661.93
- MFC $8.25
- P/E Ratio
- CRNX N/A
- MFC $13.61
- Revenue Growth
- CRNX 0.51
- MFC 9.72
- 52 Week Low
- CRNX $24.10
- MFC $25.92
- 52 Week High
- CRNX $62.53
- MFC $33.07
- Technical
- Relative Strength Index (RSI)
- CRNX 58.12
- MFC 50.92
- Support Level
- CRNX $33.42
- MFC $30.49
- Resistance Level
- CRNX $37.23
- MFC $32.35
- Average True Range (ATR)
- CRNX 1.48
- MFC 0.49
- MACD
- CRNX -0.01
- MFC 0.10
- Stochastic Oscillator
- CRNX 56.59
- MFC 38.60
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.
About MFC Manulife Financial Corporation
Manulife Financial is one of the Big Three Canadian life insurers. The firm provides life insurance, annuities, and asset management products to individuals and group customers in Canada, the United States, and Asia. The Canadian business segment contributes approximately 22% of adjusted earnings. The Asia segment operates across 12 countries and contributes around 36% of earnings, with a significant presence in Hong Kong and Singapore. The US business, which primarily operates under the John Hancock brand, contributes about 23% of earnings and is one of the top 20 life insurers in the US. Manulife's global asset and wealth management business contributes approximately 20% of its earnings and had around CAD 1.03 trillion in assets under management and administration as of the end of 2024.